Clinical Trial
doi: 10.2165/00003495-198600312-00002.
Treatment of acute salpingitis with sulbactam/ampicillin. Comparison with cefoxitin
- PMID: 3013571
- DOI: 10.2165/00003495-198600312-00002
Item in Clipboard
Clinical Trial
Treatment of acute salpingitis with sulbactam/ampicillin. Comparison with cefoxitin
Drugs.
1986.
Abstract
Sulbactam/ampicillin and cefoxitin were compared in the treatment of 20 patients with acute salpingitis diagnosed during laparoscopy. Results were evaluated during laparoscopic follow-up at 2 months. Sulbactam/ampicillin appeared to be a better treatment, producing better results in tubal patency, adhesions and persistent inflammation than cefoxitin. In addition, the combination of sulbactam/ampicillin with doxycycline appears to provide better results than the combination of cefoxitin with doxycycline in chlamydial salpingitis. It is concluded that sulbactam/ampicillin is an effective treatment for nonchlamydial salpingitis.
Similar articles
-
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.Drugs. 1987 Jun;33(6):577-609. doi: 10.2165/00003495-198733060-00003. Drugs. 1987. PMID: 3038500 Review.
-
Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.Antimicrob Agents Chemother. 1991 Aug;35(8):1651-6. doi: 10.1128/AAC.35.8.1651. Antimicrob Agents Chemother. 1991. PMID: 1929337 Free PMC article. Clinical Trial.
-
[Acute bacterial salpingitis. The importance of residual inflammation. A comparative study with celioscopic control of 2 antibiotic protocols: sulbactam-ampicillin versus cefoxitin].J Gynecol Obstet Biol Reprod (Paris). 1990;19(6):765-72. J Gynecol Obstet Biol Reprod (Paris). 1990. PMID: 2147930 Clinical Trial. French.
-
Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.Drugs. 1986;31 Suppl 2:18-21. doi: 10.2165/00003495-198600312-00005. Drugs. 1986. PMID: 3013568 Clinical Trial.
-
Treatment of acute salpingitis with sulbactam/ampicillin.Suppl Int J Gynecol Obstet. 1989;2:41-6; discussion 47-8. doi: 10.1016/0020-7292(89)90091-x. Suppl Int J Gynecol Obstet. 1989. PMID: 2529873 Clinical Trial.
Cited by
-
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.Drugs. 1987 Jun;33(6):577-609. doi: 10.2165/00003495-198733060-00003. Drugs. 1987. PMID: 3038500 Review.
-
Antibiotic therapy for pelvic inflammatory disease.Cochrane Database Syst Rev. 2017 Apr 24;4(4):CD010285. doi: 10.1002/14651858.CD010285.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 20;8:CD010285. doi: 10.1002/14651858.CD010285.pub3. PMID: 28436019 Free PMC article. Updated.
-
Antibiotic therapy for pelvic inflammatory disease.Cochrane Database Syst Rev. 2020 Aug 20;8(8):CD010285. doi: 10.1002/14651858.CD010285.pub3. Cochrane Database Syst Rev. 2020. PMID: 32820536 Free PMC article.
-
Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.Antimicrob Agents Chemother. 1991 Aug;35(8):1651-6. doi: 10.1128/AAC.35.8.1651. Antimicrob Agents Chemother. 1991. PMID: 1929337 Free PMC article. Clinical Trial.
-
Beta-lactamase inhibitors from laboratory to clinic.Clin Microbiol Rev. 1988 Jan;1(1):109-23. doi: 10.1128/CMR.1.1.109. Clin Microbiol Rev. 1988. PMID: 3060240 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
